NCT00131768已完成3 期
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis
Genzyme, a Sanofi Company10 个研究点 分布在 3 个国家开始时间: 2003年11月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 10
- 主要终点
- Pain relief
研究概览
简要总结
This clinical study is to evaluate the safety and efficacy of Synvisc in patients with symptomatic ankle osteoarthritis (OA). Patients will be given Synvisc, with the possible administration of a second injection where insufficient symptomatic pain relief was experienced during the initial 3 months follow up period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with symptomatic OA pain of ankle (talo-crural)
排除标准
- •Patients with current or prior conditions or treatments that would impede measurements of efficacy or safety
结局指标
主要结局
Pain relief
次要结局
未报告次要终点
研究者
研究点 (10)
Loading locations...
相似试验
已完成
3 期
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder OsteoarthritisMusculoskeletal DiseasesOsteoarthritisNCT00131300Genzyme, a Sanofi Company
已完成
3 期
A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the HipOsteoarthritis, HipMusculoskeletal DiseasesNCT00131326Genzyme, a Sanofi Company
已完成
不适用
Randomized Evaluation of the Efficacy of Synvisc-One® for the Treatment of Patellofemoral ChondromalaciaChondromalacia PatellaPatellofemoral Pain SyndromeNCT01771952University of Virginia86
已完成
3 期
A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the KneeMusculoskeletal DiseasesOsteoarthritis, KneeNCT00131352Genzyme, a Sanofi Company253
已完成
2 期
Synvisc to Treat Osteoarthritis of the Temporomandibular JointOsteoarthritisNCT00078351National Institute of Dental and Craniofacial Research (NIDCR)60